Stockscreener 앱 받기
3.83
1.32%
0.05
시장 영업 전:
4.19
0.36
+9.40%
전일 마감가:
$3.78
열려 있는:
$3.78
하루 거래량:
978.63K
Relative Volume:
1.13
시가총액:
$487.14M
수익:
$81.36M
순이익/손실:
$-142.62M
주가수익비율:
-3.1893
EPS:
-1.2009
순현금흐름:
$-146.97M
1주 성능:
-2.79%
1개월 성능:
+0.79%
6개월 성능:
-14.13%
1년 성능:
+167.83%
1일 변동 폭
$3.72
$3.845
1주일 범위
$3.665
$4.09
52주 변동 폭
$1.225
$4.98
Adc Therapeutics Sa Stock (ADCT) Company Profile
명칭
Adc Therapeutics Sa
전화
41 21 653 02 00
주소
BIOPOLE, EPALINGES
Compare ADCT vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADCT
Adc Therapeutics Sa
|
3.83 | 487.14M | 81.36M | -142.62M | -146.97M | -1.2009 |
VRTX
Vertex Pharmaceuticals Inc
|
423.92 | 107.83B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
701.42 | 73.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
783.50 | 48.72B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
296.11 | 39.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
293.86 | 32.66B | 5.36B | 287.73M | 924.18M | 2.5229 |
Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-08 | 개시 | Stephens | Overweight |
| 2024-05-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-03-28 | 개시 | Guggenheim | Buy |
| 2023-08-10 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-04-24 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-12-06 | 개시 | CapitalOne | Overweight |
| 2022-11-09 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-09-21 | 개시 | JP Morgan | Overweight |
| 2022-09-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-09 | 개시 | Wolfe Research | Outperform |
| 2021-08-17 | 재개 | Jefferies | Buy |
| 2021-08-09 | 개시 | RBC Capital Mkts | Outperform |
| 2021-06-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-12-03 | 개시 | Stifel | Hold |
| 2020-10-29 | 개시 | H.C. Wainwright | Buy |
| 2020-06-09 | 개시 | BofA/Merrill | Buy |
| 2020-06-09 | 개시 | Cowen | Outperform |
모두보기
Adc Therapeutics Sa 주식(ADCT)의 최신 뉴스
Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year? - Yahoo Finance Australia
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - ChartMill
MSN Money - MSN
ADC Therapeutics (ADCT) Projected to Post Quarterly Earnings on Monday - MarketBeat
ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026 - Nasdaq
ADC Therapeutics outlines $600M–$1B peak revenue target for ZYNLONTA as LOTIS-5 and LOTIS-7 advance - MSN
ADC Therapeutics rises on $60M PIPE financing - MSN
ADC Therapeutics schedules May 4 webcast on Q1 results and operations - Stock Titan
Redmile Group (NASDAQ: ADCT) reports 9.9% stake after SPV reorg - Stock Titan
ADC Therapeutics S.A. Investigated by the Portnoy Law Firm - GlobeNewswire
ADC Therapeutics SA ($ADCT) CEO 2025 Pay Revealed - Quiver Quantitative
Executive pay, equity plan and capital changes at ADC Therapeutics (ADCT) - Stock Titan
ADC Therapeutics (NASDAQ: ADCT) adds SILV Fund as selling shareholder - Stock Titan
ADC Therapeutics (NYSE:ADCT) Shares Up 11.8%Still a Buy? - MarketBeat
Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update - ADVFN
ADC Therapeutics (NYSE: ADCT) to hold virtual AGM June 1; votes on capital and pay - Stock Titan
Aug Spikes: Can ADC Therapeutics SA continue delivering strong returns2026 Key Lessons & High Accuracy Trade Signal Alerts - baoquankhu1.vn
ADC Therapeutics SA $ADCT Stock Holdings Raised by JPMorgan Chase & Co. - MarketBeat
ADCT.N Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
ADCT.N Technical Analysis & Stock Price Forecast - Intellectia AI
Redmile Group, Jeremy Green disclose 9.99% stake in ADC Therapeutics (ADCT) - Stock Titan
Risk Off: Does ADC Therapeutics SA have a sustainable dividendWeekly Profit Analysis & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Insider Sell: What is the implied volatility of ADC Therapeutics SA2026 Review & AI Enhanced Execution Alerts - baoquankhu1.vn
ADCT News & Events - Intellectia AI
ADCT Should I Buy - Intellectia AI
ADCT.N PE Ratio & Valuation, Is ADCT.N Overvalued - Intellectia AI
Next Generation Drug Conjugates (NDCs) Market Worth $42.55 Billion by 2035 | MarketsandMarkets - 富途牛牛
ADCT Stock Analysis: ADC Therapeutics SA Common Shares at $3.78 after 0.53pct dip - Cổng thông tin điện tử Tỉnh Sơn La
Insider Selling: ADC Therapeutics (NYSE:ADCT) Major Shareholder Sells $8,641,179.68 in Stock - MarketBeat
Insider Selling: ADC Therapeutics (NYSE:ADCT) Major Shareholder Sells 196,229 Shares of Stock - MarketBeat
Redmile-managed funds trim ADC Therapeutics (ADCT) stake with 5.9M-share sale - Stock Titan
ADC Therapeutics Announces New Employee Inducement Grant - Financial Times
Energy Moves: Is ADC Therapeutics SA in a consolidation phase2026 Retail Activity & Real-Time Volume Spike Alerts - baoquankhu1.vn
Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Nasdaq Moves: Is ADC Therapeutics SA a stock for growth or value investors2026 Setups & High Accuracy Buy Signal Tips - baoquankhu1.vn
ADC Therapeutics Eyes ZYNLONTA Expansion as LOTIS-5 Data Nears at H.C. Wainwright Chat - MarketBeat
ADC Therapeutics (NYSE:ADCT) Shares Gap Up on Analyst Upgrade - Defense World
ADC Therapeutics (NYSE:ADCT) Price Target Raised to $8.00 - MarketBeat
ADC Therapeutics (ADCT) Reports 2025 Revenue of $73.6M With Cash Runway Into 2028 - Yahoo Finance
US Stocks Recap: Can ADC Therapeutics SA disrupt its industryRate Hike & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Heights Capital Management Inc. Has $1.31 Million Position in ADC Therapeutics SA $ADCT - MarketBeat
Growth Recap: Will ADC Therapeutics SA benefit from rate cuts2026 Dividend Review & Technical Entry and Exit Tips - baoquankhu1.vn
Fed Watch: Is ADC Therapeutics SA stock showing strong momentumMarket Rally & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
[EFFECT] ADC Therapeutics SA SEC Filing - Stock Titan
ADC Therapeutics (ADCT) registers 9.83M shares issuable on HCR warrants - Stock Titan
Adc Therapeutics Sa (ADCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.45%
자본화:
|
볼륨(24시간):